In accordance with the research directions set in the “14th Five-year plan” and discuss the key scientific research topics critical to national safety and public health, and to promote research-industrial collaborations, CAS Laboratory for Pathogenic Microbiology and Immunology (CAS-PMI for short), and Chinese Bioengineering Society (Gaochun) Collaborative Center for Innovation, as well as the Amino Acid Industrial Expert Committee of Chinese Bioengineering Society hold the “Gaochun Summit for Biomedicine and Health Industry”on 20-21 October 2020 in Gaochun, Nanjing, hosted by Nanjing Zhongkeyouzi Institute of Biotechnology Co., Ltd.
IM-CAS committee secretary Junxiong Li represented the institute and delivered the opening mark for the summit; Weixing Song, representative of Gaochun district followed with introduction of the industrial planning and future layout. Deputy director of CAS-PMI, Prof Yi Shi summarized in his report the recent progress made by CAS-MPI, including current research directions, scientific output and planned areas for future development. Group leader Prof Tingyi Wen focused on the projects development and industrial translation of Nanjing Zhongkeyouzi Institute of Biotechnology Co., Ltd. Lastly, Prof Shiping Jiao of Nanjing Gulou hospital presented his recent work on immune therapy of cancers in the clinical settings.
This summit is diverse and rich in discussed topics, and presented in a well-received format in terms of scientific content; its success further promotes the scientific exchange as well as actualization of biomedicine and health industry, and eventually also Beijing-Nanjing cooperation and cross-disciplinary interactions.